← Leaderboards
Ronald B Goldberg
University Of Miami School Of Medicine
$14,882,436
Attributed
$14,882,436
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.8M · FY2005–22$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$14,882,436 · 5
By mechanism
U01$9,274,356 · 1
P01$3,999,244 · 2
R01$1,496,697 · 1
M01$112,139 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Metformin”
- David M Nathan · Massachusetts Institute Of Technology$131,567,540
- John M Lachin · George Washington University$118,921,924
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$57,671,528
- Sarah E. Fowler · George Washington University$37,648,866
- Jose A Luchsinger · Columbia University Health Sciences$37,118,016
- Supriya Menezes · The Emmes Company, Llc$25,277,032
Research focus
MetforminRisk FactorsDiabetes MellitusLifestyle InterventionBaseLife StylePreventCardiovascular Disorder RiskNon-Insulin-Dependent Diabetes MellitusQuality Of LifeCardiovascular DiseasesGlucosePlacebosDiabetes Prevention ProgramFollow-UpCohortProgramsAtherosclerosisBiochemicalLong-Term EffectsPhenotypeFunctional DisorderObesityMetabolic
Grant awards (43)
4/22 Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) â Clinical Center$101,840
U01 · FY2022 · DK · contact PI
4/22 Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) â Clinical Center$151,599
U01 · FY2021 · DK · contact PI
04/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 â Research Project$357,279
U01 · FY2020 · DK · contact PI
04/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 â Research Project$381,292
U01 · FY2019 · DK · contact PI
04/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 â Research Project$407,812
U01 · FY2018 · DK · contact PI
04/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 â Research Project$340,244
U01 · FY2017 · DK · contact PI
04/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 â Research Project$345,105
U01 · FY2016 · DK · contact PI
04/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 â Research Project$39,910
U01 · FY2016 · DK · contact PI
04/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 â Research Project$23,952
U01 · FY2016 · DK · contact PI
DDP LONG-TERM FOLLOW-UP STUDY$305,924
U01 · FY2015 · DK · contact PI
DDP LONG-TERM FOLLOW-UP STUDY$334,465
U01 · FY2014 · DK · contact PI
DDP LONG-TERM FOLLOW-UP STUDY$563,073
U01 · FY2013 · DK · contact PI
DDP LONG-TERM FOLLOW-UP STUDY$539,362
U01 · FY2012 · DK · contact PI
DDP LONG-TERM FOLLOW-UP STUDY$486,801
U01 · FY2011 · DK · contact PI
Biobehavioral Bases & Management of Metabolic Syndrome$479,784
P01 · FY2011 · HL · contact PI
Core--Endocrinology and Metabolism$252,953
P01 · FY2011 · HL · contact PI
Biobehavioral Bases & Management of Metabolic Syndrome$518,919
P01 · FY2010 · HL · contact PI
Biomarkers and Outcomes in the Diabetes Prevention Program$505,096
R01 · FY2010 · DK · contact PI
DDP LONG-TERM FOLLOW-UP STUDY$459,000
U01 · FY2010 · DK · contact PI
Core--Endocrinology and Metabolism$289,332
P01 · FY2010 · HL · contact PI
Biobehavioral Bases & Management of Metabolic Syndrome$541,389
P01 · FY2009 · HL · contact PI
Biomarkers and Outcomes in the Diabetes Prevention Program$497,141
R01 · FY2009 · DK · contact PI
DDP LONG-TERM FOLLOW-UP STUDY$459,000
U01 · FY2009 · DK · contact PI
Core--Endocrinology and Metabolism$276,728
P01 · FY2009 · HL · contact PI
Biobehavioral Bases & Management of Metabolic Syndrome$530,413
P01 · FY2008 · HL · contact PI
Biomarkers and Outcomes in the Diabetes Prevention Program$494,460
R01 · FY2008 · DK · contact PI
Post Diabetes Prevention Program Follow-up Study$441,632
U01 · FY2008 · DK · contact PI
Core--Endocrinology and Metabolism$228,893
P01 · FY2008 · HL · contact PI
Biobehavioral Bases & Management of Metabolic Syndrome$527,289
P01 · FY2007 · HL · contact PI
Post Diabetes Prevention Program Follow-up Study$269,622
U01 · FY2007 · DK · contact PI
Core--Endocrinology and Metabolism$236,500
P01 · FY2007 · HL · contact PI
Post DPP Follow-up Study$414,556
U01 · FY2006 · DK · contact PI
Post DPP Follow-up Study$406,034
U01 · FY2005 · DK
DIABETES PREVENTION PROGRAM OUTCOMES STUDY$34,016
M01 · FY2005 · RR
Post DPP Follow-up Study$403,517
U01 · FY2004 · DK
CORE B--$117,044
P01 · FY2004 · HL
Diabetes Prevention Program Outcomes Study$78,123
M01 · FY2004 · RR
Post DPP Follow-up Study$384,993
U01 · FY2003 · DK
NIDDM PRIMARY PREVENTION TRIAL (DPT-2)$343,806
U01 · FY2002 · DK
CORE--ENDOCRINOLOGY AND METABOLISM$0
P01 · FY2002 · HL
NIDDM PRIMARY PREVENTION TRIAL (DPT-2)$684,655
U01 · FY2001 · DK
CORE--ENDOCRINOLOGY AND METABOLISM$0
P01 · FY2001 · HL
NIDDM PRIMARY PREVENTION TRIAL (DPT-2)$628,883
U01 · FY2000 · DK